X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
infectious diseases (26) 26
immunology (25) 25
index medicus (22) 22
virology (20) 20
hiv infections - drug therapy (18) 18
hiv (17) 17
hiv infections - virology (17) 17
adult (15) 15
male (15) 15
hiv infections - immunology (14) 14
middle aged (14) 14
female (13) 13
hiv-1 - genetics (13) 13
hiv infection (12) 12
antiretroviral therapy (9) 9
cd4 t-cells (9) 9
cd4-positive t-lymphocytes - immunology (9) 9
expression (9) 9
lymphocytes (9) 9
research (9) 9
aids/hiv (8) 8
cd4 lymphocyte count (8) 8
cd4-positive t-lymphocytes - virology (8) 8
health aspects (8) 8
microbiology (8) 8
replication (8) 8
drug therapy (7) 7
hiv-1 - physiology (7) 7
human immunodeficiency virus--hiv (7) 7
in-vitro (7) 7
infection (7) 7
reservoir (7) 7
virus diseases (7) 7
viruses (7) 7
abridged index medicus (6) 6
anti-hiv agents - therapeutic use (6) 6
antiretroviral drugs (6) 6
antiviral agents (6) 6
hiv-1 (6) 6
hiv-1 - drug effects (6) 6
hiv-1 - isolation & purification (6) 6
immunodeficiency-virus type-1 (6) 6
in-vivo (6) 6
physiological aspects (6) 6
t cells (6) 6
viral load (6) 6
article (5) 5
cd4 (5) 5
cd4-positive t-lymphocytes - drug effects (5) 5
cells, cultured (5) 5
genetic aspects (5) 5
infections (5) 5
latency (5) 5
virus latency (5) 5
virus latency - drug effects (5) 5
activation (4) 4
aids (4) 4
antiretroviral therapy, highly active (4) 4
base sequence (4) 4
blood (4) 4
care and treatment (4) 4
cell line (4) 4
cytoskeleton (4) 4
dna (4) 4
hiv infections - pathology (4) 4
hiv-1 - immunology (4) 4
hiv/aids (4) 4
human immunodeficiency virus (4) 4
immune activation (4) 4
multidisciplinary sciences (4) 4
polymerase chain reaction (4) 4
research article (4) 4
treatment outcome (4) 4
viremia (4) 4
active antiretroviral therapy (3) 3
aged (3) 3
aging (3) 3
anti-retroviral agents - therapeutic use (3) 3
antiretrovirals (3) 3
australia (3) 3
biology and life sciences (3) 3
blood banks (3) 3
cd4 antigen (3) 3
cd4-positive t-lymphocytes (3) 3
chemokines (3) 3
cross-sectional studies (3) 3
dendritic cells (3) 3
dendritic cells - virology (3) 3
development and progression (3) 3
gene expression (3) 3
hiv 1 (3) 3
hiv-1 - pathogenicity (3) 3
human-immunodeficiency-virus (3) 3
ipilimumab (3) 3
kinetics (3) 3
lymphocyte activation (3) 3
lymphocytes t (3) 3
medicine and health sciences (3) 3
models, immunological (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Pathogens, ISSN 1553-7366, 11/2014, Volume 10, Issue 11, p. e1004473
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 09/2016, Volume 7, Issue 1, p. 12731
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 7, pp. 1157 - 1165
Background. Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related... 
T lymphocytes | HIV/AIDS | Telomeres | Antiretrovirals | HIV | Final causes | Cell lines | Nucleosides | Reverse transcriptase inhibitors | Carts | Disease risks | telomerase | aging | HIV infection | antiretroviral therapy | telomere | INFECTIOUS DISEASES | HUMAN HL60 CELLS | ANTIRETROVIRAL NUCLEOSIDE | ALZHEIMERS-DISEASE | LENGTH | MICROBIOLOGY | IMMUNOLOGY | CANCER | CD8(+) T-CELLS | IN-VITRO | THERAPY | INFECTION | UP-REGULATION | Humans | Middle Aged | Aging - drug effects | Antiretroviral Therapy, Highly Active - adverse effects | Male | Telomere - drug effects | Case-Control Studies | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Tenofovir | Young Adult | Telomere Shortening | Adenine - adverse effects | HIV Infections - pathology | Time Factors | Polymerase Chain Reaction | Adult | Deoxycytidine - adverse effects | Female | Telomerase - metabolism | Dideoxynucleosides - adverse effects | Emtricitabine | Adenine - analogs & derivatives | Leukocytes, Mononuclear - drug effects | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Risk Factors | Cells, Cultured | Organophosphonates - adverse effects | HIV - pathogenicity | Enzyme Activation - drug effects | Regression Analysis | Telomere - enzymology | HIV Infections - drug therapy | Leukocytes, Mononuclear - enzymology | Telomerase - antagonists & inhibitors | Deoxycytidine - analogs & derivatives | Complications and side effects | Demographic aspects | Physiological aspects | Aging | Research | Telomerase
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2010, Volume 202, Issue 8, pp. 1254 - 1264
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 03/2017, Volume 215, Issue 6, pp. 911 - 919
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 11, p. e109718
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158778
Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed. In this study, we examined... 
REPLICATION | MULTIDISCIPLINARY SCIENCES | TRANSCRIPTION | IMMUNODEFICIENCY-VIRUS TYPE-1 | CHEMOKINE RECEPTOR | CD4(+) T-CELLS | INFECTION | ACTIN CYTOSKELETON | RESTRICTION | IDENTIFICATION | LYMPHOCYTES | Coculture Techniques | Dendritic Cells - immunology | Humans | Host-Pathogen Interactions - drug effects | Virus Latency - drug effects | Receptors, CCR5 - immunology | Host-Pathogen Interactions - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - physiology | Interleukin-2 - immunology | Dendritic Cells - drug effects | CD4-Positive T-Lymphocytes - virology | Chemokine CCL19 - immunology | Dendritic Cells - virology | HIV Infections - blood | HIV Infections - virology | Cells, Cultured | HIV-1 - immunology | Models, Immunological | Chemokine CCL19 - pharmacology | Receptors, CXCR4 - immunology | Interleukin-2 - pharmacology | Virus Latency - immunology | CD4-Positive T-Lymphocytes - drug effects | Research | HIV (Viruses) | T cells | Virus latency | HIV infection | Analysis | CCR5 protein | CCL19 protein | Dendritic cells | Variability | Latent infection | Viruses | Infections | Lymphocytes T | Blood banks | CXCR4 protein | CD4 antigen | Latency | Virology | Ethics | Infectious diseases | Immunology | Interleukin 2 | Efficiency | Plasmids | Lymphocytes | Human immunodeficiency virus--HIV | Cytoskeleton | Chemokines | Deoxyribonucleic acid--DNA | Deoxyribonucleic acid | HIV | DNA | Human immunodeficiency virus
Journal Article
Blood, ISSN 0006-4971, 12/2007, Volume 110, Issue 13, pp. 4161 - 4164
Journal Article